Ola Folarin,MD

AP/CP: PennMedicine, Cytopathology: NYP-WCM, Breast Pathology:MSKCC

[Ola Folarin,MD @efohess]

#NewProfilePic

[Ola Folarin,MD @efohess]

Dinner with Prof @mtsiddi and his Past Fellows. Hearts full of gratitude! #ASCyto25 @HeymannJonas

[Cancer Cytopathology @CancerCytopath]

Free access!🔬 Are we on track for diagnosing high-grade urothelial carcinoma with a minimum quantity of 5 malignant cells in lower tract specimens? Critical analysis of The #ParisSystem Quantitation Criteria

https://t.co/6Fgx8ANcdI

#CytoPath @efohess @mtsiddi

[Ola Folarin,MD @efohess]

@Paeanox @StanfordPath @HirtChristian @NivazB Congratulations🎉🎊 Parnaz!

[Ola Folarin,MD @efohess]

@Hussain78496581 @shwetmike I have a possible missing baggage (x4)! I have DM you but no response! Emailed baggage and claims, nothing! It’s my family’s first time with EGYPTAIR and this is plain “horror”!

[Hannah Wen @HannahYWen]

Great presentation “Enhancing Breast Pathology: Clinical Validation of AI-Assisted Diagnosis” by our Breast Pathology fellow Olawunmi Folarin @MSKPathology at the Breast Pathology Platform. Congratulations! @MSKPathology @MGHannaMD @EdiBrogi @rovingatuscap #USCAP2024 #breastpath

[Ola Folarin,MD @efohess]

@TheUSCAP #USCAP2024 #BreastPathPoster AR in TNBC

[Ola Folarin,MD @efohess]

@TheUSCAP @MSKPathology #BreastPath #BreastPathAI

[Zubair Baloch @aakasharmand]

#USCAP2024 USCAP honors Dr LiVolsi @PennPathLabMed

[Cancer Cytopathology @CancerCytopath]

Hot off the press 📰🔬 | The authors conclude that interobserver agreement is excellent using the 5 Yokohama System categories in liquid-based cytology.

https://t.co/52S6MhOaGV

@efohess @mtsiddi #CytoPath

[Ola Folarin,MD @efohess]

#ASCyto23 president-elect @mtsiddi @cytopathology @WCMCPathology

[Ola Folarin,MD @efohess]

Good to see you again @Kristen__Atkins #ASCyto23 where cyto+breast pathologists meet😘

[Ola Folarin,MD @efohess]

#ASCyto23 @MSKPathology at the ASC scientific meeting in Austin Texas

[Ola Folarin,MD @efohess]

#ASCyto23 scientific meeting is live! @HeymannJonas

[Dina Zenezan,MD @DZenezan]

Very nice start in the first day of the #ASCyto23 meeting ! Happy to meet amazing colleagues and future cytopathologists! #Cytology #CytoPath @templepathology

[Parnaz Danesh @Paeanox]

Congratulations to our very own Dr. LiVolsi @LivolsiVirginia @PennPathLabMed @PennMedicine for receiving the CAP lifetime achievement award. #cap23 #PathTwitter #pathX #cap2023

[Ola Folarin,MD @efohess]

@ALBoothMD @wusm_pathology @NU_Pathology @XiuliLiu1 @washupathedu @navale_pooja @fouad_boulos @TrieuMD @KMirza @HansiniMD Congratulations 🎊 and best wishes!

[Ola Folarin,MD @efohess]

@fouad_boulos @wusm_pathology @washupathedu I’ll say dcis, low grade, background adh.

[Ola Folarin,MD @efohess]

@fouad_boulos ADH

[Ola Folarin,MD @efohess]

@mtsiddi I appreciate your mentorship. Thank you, sir!

[Ola Folarin,MD @efohess]

https://t.co/10NUN4a0kM